Whittaker, RobertEconomopoulou, AssimoulaDias, Joana GomesBancroft, ElizabethRamliden, MiriamCelentano, Lucia PastoreEuropean Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease.2019-03-202019-03-202017-03Emerg Infect Dis. 2017 Mar;23(3):396-404. doi: 10.3201/eid2303.161552.1080-6040http://hdl.handle.net/10400.18/6245European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenzae Disease: INSA - Paula LavadoWe describe the epidemiology of invasive Haemophilus influenzae disease during 2007-2014 in 12 European countries and assess overall H. influenzae disease trends by serotype and patient age. Mean annual notification rate was 0.6 cases/100,000 population, with an increasing annual trend of 3.3% (95% CI 2.3% to 4.3%). The notification rate was highest for patients <1 month of age (23.4 cases/100,000 population). Nontypeable H. influenzae (NTHi) caused 78% of all cases and showed increasing trends among persons <1 month and >20 years of age. Serotype f cases showed an increasing trend among persons >60 years of age. Serotype b cases showed decreasing trends among persons 1-5 months, 1-4 years, and >40 years of age. Sustained success of routine H. influenzae serotype b vaccination is evident. Surveillance systems must adopt a broad focus for invasive H. influenzae disease. Increasing reports of NTHi, particularly among neonates, highlight the potential benefit of a vaccine against NTHi.engAdolescentAdultChildChild, PreschoolEuropeHaemophilus InfectionsHaemophilus influenzaeHumansInfantMiddle AgedRetrospective StudiesSerogroupYoung AdultInfecções Respiratóriasjournal article10.3201/eid2303.161552